IndraLab

Statements


BCL6 activates TNFAIP3. 1 / 1
| 1

reach
"Two mutations (B-cell chronic lymphocytic leukemia/lymphoma 6 [BCL6] leucine to serine change at position 677 [L677S] in patient 1 and tumor necrosis factor, alpha induced protein 3 [TNFAIP3] proline to serine change at position 481 [P481S] in patient 5) were called in all 3 samples that were sequenced."